Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Nature Communications
|
August 10, 2016
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
Christopher A Miller, Yevgeniy Gindin, Charles Lu, et al.
Cell
|
September 18, 2012
Genomic landscape of non-small cell lung cancer in smokers and never-smokers
Ramaswamy Govindan, Li Ding, Malachi Griffith, et al.
The Lancet. Oncology
|
April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
Cell Reports. Medicine
|
September 19, 2023
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
Syeda Maheen Batool, Tiffaney Hsia, Alexandra Beecroft, et al.
JAMA Oncology
|
February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
Otto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Journal of the National Cancer Institute
|
January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)
Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Journal of Clinical Pharmacology
|
May 2, 2003
Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop
Lawrence J Lesko, Ronald A Salerno, Brian B Spear, et al.
Molecular and Cellular Biology
|
August 26, 2009
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
Mark Watson, Anne Roulston, Laurent Bélec, et al.
The Journal of Allergy and Clinical Immunology
|
February 19, 2019
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms
Katherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, et al.
Blood
|
December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Zhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Nature Communications
|
August 10, 2016
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
Christopher A Miller, Yevgeniy Gindin, Charles Lu, et al.
Cell
|
September 18, 2012
Genomic landscape of non-small cell lung cancer in smokers and never-smokers
Ramaswamy Govindan, Li Ding, Malachi Griffith, et al.
The Lancet. Oncology
|
April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
Cell Reports. Medicine
|
September 19, 2023
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
Syeda Maheen Batool, Tiffaney Hsia, Alexandra Beecroft, et al.
JAMA Oncology
|
February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
Otto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Journal of the National Cancer Institute
|
January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)
Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Journal of Clinical Pharmacology
|
May 2, 2003
Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop
Lawrence J Lesko, Ronald A Salerno, Brian B Spear, et al.
Molecular and Cellular Biology
|
August 26, 2009
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
Mark Watson, Anne Roulston, Laurent Bélec, et al.
The Journal of Allergy and Clinical Immunology
|
February 19, 2019
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms
Katherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, et al.
Blood
|
December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Zhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.
Page
of 11